Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV
ID: NIH/NIAID 127Type: BOTH
Overview

Topic

Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2023

Topic Link

https://www.sbir.gov/node/2451731

Additional Information

https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view
Timeline
  1. 1
    Release Aug 25, 2023 12:00 AM
  2. 2
    Open Aug 25, 2023 12:00 AM
  3. 3
    Next Submission Due Nov 14, 2023 12:00 AM
  4. 4
    Close Nov 14, 2023 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for Small Business Innovation Research (SBIR) contract proposals. The specific topic of the solicitation is "Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV".

The goal of this research is to develop innovative strategies to target hard-to-reach populations and facilitate earlier detection, diagnosis, and linkage to care and treatment for people living with hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV. The solicitation highlights the importance of self-testing as an approach to increase access to and uptake of testing among key populations.

The solicitation accepts Phase I or Fast Track proposals, with a total budget of $300,000 for up to 1 year. Phase II proposals are also accepted, with a budget of $2 million for up to 3 years. The anticipated number of awards is 2-3.

Overall, this solicitation aims to support the development of multiplexed patient-administered tests that can overcome barriers to healthcare access and stigma, increase access to testing, facilitate early diagnosis and treatment initiation, reduce transmission, and improve health outcomes for currently undiagnosed and hard-to-reach populations.

Files
No associated files provided.
Similar Opportunities
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) - https://grants.nih.gov/grants/guide/PA-files/PAR-24-158.html
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics through their Small Business Innovation Research (SBIR) program. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that address health disparities created by clinical laboratory assays and point-of-care devices that fail to incorporate diverse patient groups. The goal is to develop clinical diagnostics that are accessible to populations that experience health disparities and to eliminate health inequities. The research objectives include developing clinical diagnostics that meet or exceed the quality of existing diagnostics, considering social determinants of health during the development process, and including input from relevant populations that experience health disparities. The funding opportunity accepts various types of projects, such as novel technologies addressing known issues in existing diagnostics, projects addressing health inequities in analytics or bioinformatics, and pilot or small-scale projects validating new technology. The funding is available for both Phase I and Phase II projects, with the option for a Fast Track application. The National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Sexual & Gender Minority Research Office, and the National Human Genome Research Institute are also participating in this funding opportunity.
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) - https://grants.nih.gov/grants/guide/PA-files/PAR-24-158.html
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics through their Small Business Innovation Research (SBIR) program. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies addressing known issues in existing diagnostics, projects addressing health disparities in analytics or bioinformatics, and pilot or small-scale projects validating new technology. The funding is divided into different phases, including Phase I to establish technical feasibility and Phase II for further development and commercialization. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Sexual & Gender Minority Research Office (SGMRO) are also participating in this funding opportunity, each with their specific research priorities. The National Human Genome Research Institute (NHGRI) encourages comprehensive genomics research with commercial potential. The solicitation is currently open, with multiple application due dates throughout the year. For more information, refer to the solicitation agency URL provided.
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies, analytics or bioinformatics, clinical decision support tools, and pilot or small-scale projects. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. More information can be found on the grants.gov website.
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of unlicensed products, or administration of licensed products for unapproved indications. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, study management and oversight, safety monitoring, and regulatory activities. The project duration is not specified, but the solicitation is open until January 14, 2027. The funding specifics can be found on the grants.nih.gov website.
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, safety monitoring, and regulatory activities. The project duration is not specified, but the application due dates are provided. More information can be found on the grants.gov website.